Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.
about
Helicobacter infection in hepatocellular carcinoma tissue.Association between the presence of H pylori in the liver and hepatocellular carcinoma: a meta-analysisTranscatheter arterial chemoembolization: history for more than 30 years.Hepatocellular carcinoma: epidemic and treatment.Treatment of hepatocarcinoma.Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis.Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosisAssessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.Immunological treatment of liver tumorsOutcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombusHepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy.Postoperative therapy options for hepatocellular carcinoma.Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm.Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors.Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis.Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells.A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma.Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma.P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma.Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection.Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion.The status of transarterial chemoembolization treatment in the era of precision oncology.High expression of Parkin predicts easier recurrence of patients with adjuvant transarterial chemoembolization.Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver.Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach
P2860
Q33868814-6A8596DE-1A26-49EC-A9A0-42B516B33E7AQ34586952-BB59CCC9-5889-40FC-977A-9F6B85EA3E6DQ34642418-E4449830-65CD-4E31-A6A5-DD3A7E6052C4Q35739058-592457A5-CAD8-4CE2-899C-C8CD0E67BBD4Q35739061-F1BEE7C6-077D-46F5-8423-BD0641EAC4A5Q36065568-15590BAA-2CDA-46A3-AF03-945FC9860C27Q36178081-09007306-BD18-48B3-B244-0A5756F15E2AQ36213803-2C78D09E-C409-4ED7-94F5-4059766D9638Q36308295-2F6DFD09-ECAF-4932-B3F2-E9A1C51B9A55Q36373254-7877D8DF-56F2-4A2A-B2FE-C6A8CA8A269AQ36700251-24EF3EF7-25D7-4F91-B1F9-0B332C1833A6Q36934253-6C9BD8FC-1095-4C2E-A3E8-8249384434C0Q37058807-B8FF5C04-E116-4613-A54D-29514BF29349Q37288364-6689AB35-ABF9-42DC-BBD2-A016DEF36983Q38203306-202D5791-5908-4256-9F0C-52BF96068014Q38445388-F1BE1138-FDBF-40F1-9945-A4823B41F2A8Q38620322-1952E05D-15CE-455D-BF2B-B17A8888E512Q40347323-8F3995D4-CAAB-4C97-88F6-C76044A42786Q40462976-E1A80A63-0DCD-49B7-A65E-A06985A86839Q42002394-1C583A90-5132-4A4E-B51F-E670F9D1C9FFQ43083274-96A4226E-6CD1-4CC4-AEB8-14D26673AA5AQ45412652-1259D530-5688-48FE-A48C-440D5C33914EQ45492170-413E66C5-6689-408E-874D-8D95D6AFE1C1Q45720793-C76A62A3-7076-4647-B366-97F3AA51DFA0Q45745392-01C995F0-006F-4765-9A2C-C27A4F9EF5C4Q46396394-D85A6D8A-3D40-453D-935C-D64581581E03Q49491370-6247B0D1-8584-4F74-8899-CD7B5DF23EEDQ50236833-5D08BE6B-92D0-452D-A7AC-C61DC49FC762Q51775986-940F024D-D485-4D10-B5D3-91A9385CFF83Q53296852-804283E4-06A8-47C5-A1A2-3995B7BC34ECQ58329162-A77B20B2-C2CF-440F-9847-23D48C6686A1
P2860
Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Preventive treatments for recu ...... of randomized control trials.
@ast
Preventive treatments for recu ...... of randomized control trials.
@en
type
label
Preventive treatments for recu ...... of randomized control trials.
@ast
Preventive treatments for recu ...... of randomized control trials.
@en
prefLabel
Preventive treatments for recu ...... of randomized control trials.
@ast
Preventive treatments for recu ...... of randomized control trials.
@en
P2860
P356
P1476
Preventive treatments for recu ...... of randomized control trials.
@en
P2093
Hui-Chuan Sun
Zhao-You Tang
P2860
P304
P356
10.3748/WJG.V9.I4.635
P407
P577
2003-04-01T00:00:00Z